← P3 Health Partners Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Health plan receivable, net of allowance for credit losses of $281 and $150 as of December 31, 2025 and 2024, respectively | $45.0m | $50.3m | $72.1m | $118.5m | $121.3m | $92.5m | |
| Clinic fees, insurance and other receivables | $676k | $1.1m | $822k | $3.0m | $3.9m | $3.4m | |
| Prepaid expenses and other current assets | $5.2m | $7.0m | $2.6m | $3.6m | $14.4m | $11.4m | |
| TOTAL CURRENT ASSETS | $90.9m | $199.9m | $100.7m | $166.0m | $184.1m | $133.1m | |
| Property and equipment, net | $6.2m | $8.0m | $8.8m | $8.7m | $5.7m | $3.4m | |
| Intangible assets, net | — | $835.8m | $751.0m | $666.7m | $574.4m | $492.4m | |
| Other long-term assets | — | $10.6m | $16.0m | $19.5m | $19.2m | $27.8m | |
| Cash | $36.3m | $140.5m | $17.5m | $36.3m | $38.8m | $25.0m | |
| Restricted cash | $3.6m | $356k | $920k | $4.6m | $5.3m | $795k | |
| Assets held for sale | — | — | — | $0 | $403k | $0 | |
| Accrued expenses and other current liabilities | — | $12.3m | $16.6m | $36.9m | $29.4m | $42.4m | |
| Health plan settlements payable | $13.7m | $22.5m | $13.6m | $35.0m | $55.6m | $69.8m | |
| Claims payable | $56.9m | $102.0m | $151.2m | $178.0m | $255.1m | $287.8m | |
| Premium deficiency reserve | $0 | $37.8m | $26.4m | $13.7m | $67.4m | $86.1m | |
| Liabilities held for sale | — | — | — | $0 | $353k | $0 | |
| Operating lease liability | $3.6m | $6.3m | $11.5m | $13.6m | $11.3m | $11.5m | |
| Warrant liabilities | $6.3m | $11.4m | $1.5m | $1.1m | $10.3m | $2.5m | |
| Contingent consideration | — | $3.5m | $4.8m | $4.9m | $0 | — | |
| Redeemable non-controlling interest | — | $1.8b | $516.8m | $291.5m | $73.6m | $15.0m | |
| TOTAL STOCKHOLDERS’ (DEFICIT) EQUITY | $5.9m | $142.1m | $75.9m | ($155.2m) | |||
| TOTAL ASSETS | $106.4m | $2.4b | $876.6m | $861.0m | $783.4m | $656.6m | |
| Accounts payable | — | $5.5m | $11.5m | $8.7m | $8.4m | $11.7m | |
| Accrued payroll | $4.0m | $6.3m | $8.2m | $3.5m | $2.7m | $1.9m | |
| Accrued interest | $4.1m | $8.8m | $14.1m | $23.6m | $12.5m | $429k | |
| Current portion of long-term debt | $90k | $46k | — | $0 | $65.0m | $45.0m | |
| TOTAL CURRENT LIABILITIES | $90.6m | $198.8m | $241.7m | $299.4m | $496.4m | $545.3m | |
| Other long-term liabilities | — | — | — | $0 | $26.0m | $9.3m | |
| Long-term debt, net | $45.4m | $80.0m | $94.4m | $108.3m | $89.8m | $228.4m | |
| TOTAL LIABILITIES | $146.0m | $299.9m | $353.9m | $427.3m | $633.9m | $796.9m | |
| Common stock, shares issued (in shares) | — | — | — | $313.2m | $358.8m | $7.2m | |
| Common stock, shares outstanding (in shares) | — | — | — | 313.2m | 358.8m | 7.2m | |
| Common stock | — | $24k | $24k | $32k | $36k | $0 | |
| Additional paid in capital | — | $312.9m | $315.4m | $509.4m | $579.1m | $495.9m | |
| Accumulated deficit | ($130.5m) | ($39.4m) | ($309.5m) | ($367.3m) | ($503.2m) | ($651.1m) | |
| TOTAL LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS’ (DEFICIT) EQUITY | $106.4m | $2.4b | $876.6m | $861.0m | $783.4m | $656.6m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.